Study of iloperidone in Parkinson's disease psychosis (PDP)
Latest Information Update: 08 May 2021
At a glance
- Drugs Iloperidone (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Vanda Pharmaceuticals
- 05 May 2021 Status changed from planning to recruiting, according to a Vanda Pharmaceuticals media release.
- 17 Feb 2021 New trial record
- 10 Feb 2021 According to Vanda pharmaceutical, this study is expected to begin in the first quarter of 2021.